// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Immunodominant, Qa-1-restricted CD8 T cell response elicited against a non-canonical translation product in influenza A virus

Michael J Hogan - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Leveraging high-dimensional flow cytometry to reveal the human immune system at a population-wide scale

Thomas Andreas Liechti - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Detection and characterisation of lung-resident memory T cells in human and non-human primates

Duncan Charles Humphries - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Extensive culturing and metagenomics enable functional and taxonomic comparison of mouse and human gut microbiotas

Virginia Anh Pedicord - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

NKG2A educates uterine NK cells to optimise pregnancy outcomes in humans and mice

N Shreeve - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Host responses to feline coronavirus are significantly different in primary macrophages compared to CRFK cells.

Yvonne Drechsler - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Peritonitis

N/A

ILC2-driven innate immune checkpoint mechanism antagonizes NK cell anti-metastatic function in the lung.

Timotheus You Fu Halim - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

Interleukin

SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation

Bingyu Yan - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Ruxolitinib phosphate

Responses of injured nerve in CD137L knockout mice following sciatic nerve crush-induced neuropathic pain

Ling Cao - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pain (neuropathic)

Interleukin-10

Setting the pace: CD4 T cell-intrinsic Arginase 1 orchestrates Th1 induction and contraction

Erin E West - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hyperargininemia

Nitric oxide

A Snap Shot of Complement Gene Expression and Presence of Complement Proteins in Synovial Biopsies from Early Rheumatoid Arthritis Patients

Nirmal K Banda - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity.

Sara Herrera de la Mata - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy

Silvia Guglietta - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Bi-allelic TTC21A mutations in common variable immunodeficiency patients

Zinan Zhang - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Common variable immunodeficiency

N/A

Electromyographic characterization and bioinformatic pathway analysis of spinal cord inflammation in a Tat induced HIV-associated sensory neuropathy model

Ling Cao - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Human immunodeficiency virus infection

Doxycycline

mTOR-associated Mitochondrial Energy Metabolism Limits Mycobacterium ESX-1-induced Cytotoxicity

Antonio J Pagán - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Interleukin-10 enhances IL-33-mediated MC activation and modulates the development of food allergy

Clinton B Mathias - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin-10

Complement activates an autocrine Vitamin D system that recruits a defined transcription factor network to shut down pro-inflammatory programs of Th1 cells

Daniel C Chauss - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka

J M K Chandima Jeewandara - American Association of Immunologists (AAI) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The Effects of Stressful Life Events on Alzheimer’s Disease Biomarkers, Neuroinflammation and Brain Integrity in Later Life: A Life Course Perspective

Eleni Palpatzis - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

Interleukin

Copyright © 2026. QuantiNova All rights reserved